BRIEF published on 11/12/2024 at 15:05, 8 days 23 hours ago Disclosure of Zürcher Kantonalbank's Position in Tritax EuroBox PLC Form 8.3 Takeover Code Securities Disclosure Zürcher Kantonalbank Tritax EuroBox
PRESS RELEASE published on 11/12/2024 at 15:00, 8 days 23 hours ago Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC Zürcher Kantonalbank discloses a 0.776% ownership of Registered Shares in Tritax EuroBox PLC. Position disclosed on 11th Nov 2024 Position Disclosure Ownership Disclosure Zürcher Kantonalbank Registered Shares Tritax EuroBox Plc
BRIEF published on 11/08/2024 at 14:05, 13 days ago Zürcher Kantonalbank Discloses Position in Tritax EuroBox Takeover Code Securities Disclosure Zürcher Kantonalbank Registered Shares Tritax EuroBox
PRESS RELEASE published on 11/08/2024 at 14:00, 13 days ago Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC Zürcher Kantonalbank discloses a 1.024% stake in Tritax EuroBox PLC through registered shares. The bank sold 79,000 shares at EUR 0.841 per unit on November 7, 2024 Stake Disclosure Share Sale Zürcher Kantonalbank Registered Shares Tritax EuroBox Plc
BRIEF published on 11/07/2024 at 15:05, 13 days 23 hours ago Zürcher Kantonalbank Discloses Position on Tritax EuroBox PLC Form 8.3 Takeover Code Securities Disclosure Zürcher Kantonalbank Tritax EuroBox Plc
PRESS RELEASE published on 11/07/2024 at 15:00, 13 days 23 hours ago Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC Zürcher Kantonalbank discloses a 1.034% interest in Tritax EuroBox PLC. Shareholding increased by 170,678 shares due to transfer into ZKB over discretionary holding Disclosure Shareholding Transfer Zürcher Kantonalbank Tritax EuroBox Plc
BRIEF published on 10/11/2024 at 13:05, 1 month 10 days ago Zürcher Kantonalbank Discloses Position in Tritax EuroBox PLC Form 8.3 Takeover Code Securities Disclosure Zürcher Kantonalbank Tritax EuroBox Plc
PRESS RELEASE published on 10/11/2024 at 13:00, 1 month 10 days ago Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC Zürcher Kantonalbank discloses ownership of 1.10% of Tritax EuroBox PLC registered shares through Form 8.3 Form 8.3 Ownership Disclosure Zürcher Kantonalbank Registered Shares Tritax EuroBox Plc
BRIEF published on 07/17/2024 at 11:00, 4 months 4 days ago Zürcher Kantonalbank Discloses Position in Tritax EuroBox plc Securities Disclosure Takeover Code Zürcher Kantonalbank Tritax EuroBox Plc
PRESS RELEASE published on 07/17/2024 at 10:55, 4 months 4 days ago Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox plc Zürcher Kantonalbank discloses 1.14% ownership in Tritax EuroBox plc as of 16th July 2024 in Form 8.3 submission Securities Form 8.3 Ownership Disclosure Zürcher Kantonalbank Tritax EuroBox Plc
Published on 11/21/2024 at 14:15, 14 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 29 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 29 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 29 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 13 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 14 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 54 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 31 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 9 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 44 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 44 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
